Zhejiang Jiangbei Pharmaceutical Co., LTD., founded in July 1993, is an integrated and international pharmaceutical enterprise mainly engaged in pharmaceutical preparations, APIs and intermediates.It is honored as a national high-tech enterprise, a top 100 pharmaceutical international enterprise, a science and technology enterprise in Zhejiang Province, a key pharmaceutical enterprise in Taizhou City, a company planning to be listed in Taizhou City, a meritorious enterprise in Jiaojiang District, ranked third in Jiaojiang District's enterprise in the level of tax payment above 100 million yuan in 2022. It has 2 subsidiaries, i.e. an API and intermediate manufacturing company (Zhejiang Jiangbei Nanhai Pharmaceutical Co., Ltd.) and a trading company (Zhejiang Jiangbei Hongrui Import and Export Co., Ltd.). The company has a good product group, the formation of cardiovascular, antiviral, central nervous, digestive tract, anti-infection, anti-coagulation, anti-osteoporosis, from intermediates, APIs to solid preparations. A set of quality management system with high standards, strict requirements, continuous improvement has been established. At present, API products like Simvastatin, Atorvastatin Calcium, Levetiracetam have passed the authority inspection or certification of the US FDA, the EU CEP, WHO, the UK, Russia, Japan, South Korea, India, etc. The preparation products have also passed the inspection or certification of WHO and MHRA.